Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.028x

Based on the latest financial reports, Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a cash flow conversion efficiency ratio of 0.028x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$90.44 Million ≈ $2.85 Million USD) by net assets (NT$3.18 Billion ≈ $100.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Chunghwa Chemical Synthesis & Biotech Co stock valuation for the company's overall valuation and market capitalisation.

Chunghwa Chemical Synthesis & Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Chunghwa Chemical Synthesis & Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chunghwa Chemical Synthesis & Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chunghwa Chemical Synthesis & Biotech Co Ltd ranked by their cash flow conversion efficiency. Explore Chunghwa Chemical Synthesis & Biotech Co cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Dong Yang Pipe
KO:008970
-0.111x
KKB Engineering Berhad
KLSE:9466
-0.035x
Seoul Electronics & Telecom Co. Ltd
KQ:027040
-0.173x
Ying Han Technology Co Ltd
TW:4562
0.009x
Senkron Guvenlik ve Iletisim Sistemleri AS
IS:SNKRN
0.017x
MSC Co. Ltd
KQ:009780
0.024x
MEGA International Development Co Ltd
TWO:5529
0.360x
Korea Computer & Systems Inc
KQ:115500
0.039x

Annual Cash Flow Conversion Efficiency for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025. View Chunghwa Chemical Synthesis & Biotech Co stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 NT$3.09 Billion
≈ $97.27 Million
NT$142.61 Million
≈ $4.49 Million
0.046x -66.84%
2024-12-31 NT$3.36 Billion
≈ $105.76 Million
NT$467.65 Million
≈ $14.73 Million
0.139x +702.20%
2023-12-31 NT$3.35 Billion
≈ $105.55 Million
NT$-77.50 Million
≈ $-2.44 Million
-0.023x -110.07%
2022-12-31 NT$3.19 Billion
≈ $100.60 Million
NT$733.78 Million
≈ $23.12 Million
0.230x +203.46%
2021-12-31 NT$2.89 Billion
≈ $91.19 Million
NT$219.18 Million
≈ $6.91 Million
0.076x +36.88%
2020-12-31 NT$2.50 Billion
≈ $78.72 Million
NT$138.24 Million
≈ $4.36 Million
0.055x -58.42%
2019-12-31 NT$2.02 Billion
≈ $63.49 Million
NT$268.13 Million
≈ $8.45 Million
0.133x +12.49%
2018-12-31 NT$1.98 Billion
≈ $62.50 Million
NT$234.66 Million
≈ $7.39 Million
0.118x +35.20%
2017-12-31 NT$1.82 Billion
≈ $57.38 Million
NT$159.34 Million
≈ $5.02 Million
0.087x -40.70%
2016-12-31 NT$1.77 Billion
≈ $55.80 Million
NT$261.31 Million
≈ $8.23 Million
0.148x +245.00%
2015-12-31 NT$1.86 Billion
≈ $58.72 Million
NT$79.70 Million
≈ $2.51 Million
0.043x +199.40%
2014-12-31 NT$1.62 Billion
≈ $50.91 Million
NT$23.08 Million
≈ $727.18K
0.014x -83.17%
2013-12-31 NT$1.71 Billion
≈ $53.91 Million
NT$145.24 Million
≈ $4.58 Million
0.085x -47.02%
2012-12-31 NT$1.68 Billion
≈ $52.79 Million
NT$268.46 Million
≈ $8.46 Million
0.160x +85.46%
2011-12-31 NT$1.68 Billion
≈ $52.82 Million
NT$144.84 Million
≈ $4.56 Million
0.086x -47.25%
2010-12-31 NT$1.68 Billion
≈ $53.01 Million
NT$275.61 Million
≈ $8.68 Million
0.164x -57.67%
2009-12-31 NT$1.19 Billion
≈ $37.63 Million
NT$462.07 Million
≈ $14.56 Million
0.387x +329.84%
2008-12-31 NT$837.53 Million
≈ $26.39 Million
NT$75.39 Million
≈ $2.38 Million
0.090x --

About Chunghwa Chemical Synthesis & Biotech Co Ltd

TW:1762 Taiwan Biotechnology
Market Cap
$81.91 Million
NT$2.60 Billion TWD
Market Cap Rank
#20056 Global
#1164 in Taiwan
Share Price
NT$33.80
Change (1 day)
+0.45%
52-Week Range
NT$24.30 - NT$42.30
All Time High
NT$102.50
About

Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacturing, and sale of active pharmaceutical ingredients in Taiwan, the United States, India, Greece, Croatia, Japan, and internationally. The company offers antifungal, immunosuppressant, oncology, cardiovascular, peptide drug, immunomodulating agents, statin, muscle relaxant, ACE inhibitor with complete DM… Read more